학술논문
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Document Type
Article
Author
Alvarez-Larrán, A.; Garrote, M.; Arellano-Rodrigo, E.; Pereira, A.; Ferrer-Marín, F.; Pérez-Encinas, M.; Mata-Vazquez, M.I.; Bellosillo, B.; Gómez, M.; Hernández-Boluda, J.C.; García, R.; García-Gutiérrez, V.; Gasior, M.; Cuevas, B.; Angona, A.; Gómez-Casares, M.T.; Martínez, C.M.; Magro, E.; Ayala, R.; Carreño-Tarragona, G.; del Orbe-Barreto, R.; Pérez-López, R.; Fox, M.L.; Raya, J.-M.; Guerrero, L.; García-Hernández, C.; Caballero, G.; Murillo, I.; Xicoy, B.; Ramírez, M.J.
Source
In: Cancer . (Cancer, 1 July 2022, 128(13):2441-2448)
Subject
Language
English
ISSN
10970142
0008543X
0008543X